Posted inStock Dow futures slip 214 points amid Fed jitters: 5 things to know before Wall Street opens Dow futures were under pressure on Friday, falling about 214 points, roughly 0.5% as investors… November 14, 2025 Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Dow Jones Index forms risky pattern ahead of earnings season The Dow Jones Index has pulled back in the past few days as the recent… October 10, 2025
Posted inStock Citi sees opportunity in Oracle stock as analyst raises price target to $415 Citi analyst Tyler Radke remains optimistic on Oracle Corp. (NYSE: ORCL) despite recent volatility in… October 10, 2025
Posted inStock US stocks open in the green: S&P up 0.2%, Dow climbs 150 points US stocks ticked higher on Friday, extending weekly gains for major indexes even as Washington’s… October 10, 2025
Posted inStock Rishi Sunak joins Microsoft and Anthropic: Former UK PM enters tech, AI arena Months after returning to Goldman Sachs, former UK Prime Minister Rishi Sunak is digging deeper… October 10, 2025
Posted inStock CoreWeave insider sales show how AI IPOs are minting billionaires at record speed The artificial intelligence gold rush is not just creating new technologies — it is also… October 10, 2025
Posted inStock Levi Strauss falls 10% after cautious Q4 outlook affected by tariff worries Levi Strauss & Co. (NYSE: LEVI) shares fell sharply on Friday despite the denim maker… October 10, 2025
Posted inStock Commodity wrap: oil slumps 2% on Gaza ceasefire, gold moves back over $4,000/oz Oil prices slumped 2% on Friday as the risk premium wore off after Israel and… October 10, 2025
Posted inStock Tesla stock seesaws on Friday: here’s why Tesla stock experienced sharp swings at the bourses on Friday, capping a week marked by… October 10, 2025
Posted inStock Nvidia stock hits new all-time high, but THIS red flag may stop the bullish momentum Nvidia stock (NASDAQ: NVDA) skyrocketed to a new all-time high on Friday, driven by broader… October 10, 2025
Posted inPolitics RFK Jr shocked over pregnant moms protesting Trump with Tylenol: ‘Pathological’ ‘Trump derangement syndrome’ has spiraled to pathological levels, Health and Human Services Secretary Robert F.… October 10, 2025